FDA to speed review of generic drug applications until it’s approved three of them

T

he Food and Drug Administration on Tuesday moved to try to spur more competition in the market for generic drugs, an effort aimed at driving down prices.

In a policy change, the agency will now fast-track applications for generic drugs until three of them have been approved for a given medication. And in a broadcast to manufacturers about what it’s looking for, the FDA also published a list of about 170 categories of old drugs without generics, ranging from a glaucoma drug to the penicillin antibiotic amoxicillin.

 

Source; https://www.statnews.com/2017/06/27/fda-generic-drug-applications/

Leave a Reply